Phase II trial of trastumab and weekly paclitaxel for breast cancer. -Japan Breast Cancer Research Network (JBCRN) Trial
Phase 2
Recruiting
- Conditions
- Metastatic breast cancer
- Registration Number
- JPRN-UMIN000004819
- Lead Sponsor
- Japan Breast Cancer Research Network (JBCRN)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patient had already treated with palitaxel or trastumab. 2) anaphyaxy of durg 3) pregnant condition
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method